ORIGINAL ARTICLES Department of Chemical Technology of Drugs1, Medical University of Gdańsk, Gdańsk, Poland; Department of Pharmaceutical and Medicinal Chemistry2, Institute of Pharmacy, University of Greifswald, Greifswald, Germany Synthesis and cytotoxic evaluation of benzoxazole/benzothiazole-2- imino-coumarin hybrids and their coumarin analogues as potential anticancer agents A. MAKOWSKA1, L. WOLFF2, F. SĄCZEWSKI1,†, P. J. BEDNARSKI2,*, A. KORNICKA1,* Received July 9, 2019, accepted August 19, 2019 *Corresponding authors: Patrick J. Bednarski, Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, University of Greifswald, F.-L. Jahn Strasse 17, D-17489 Greifswald, Germany,
[email protected] Anita Kornicka, Department of Chemical Technology of Drugs, Medical University of Gdańsk, Al. Gen. J. Hallera 107, 80-416 Gdańsk, Poland
[email protected] †deceased 18.10.2018 Pharmazie 74: 648-657 (2019) doi: 10.1691/ph.2019.9664 Two series of 2-imino-coumarin based hybrids: 3-(benzoxazol-2-yl)-2H-chromen-2-imines 3-9 (series A-I) and 3-(benzothiazol-2-yl)-2H-chromen-2-imines 10-16 (series A-II), as well as their coumarin analogues: 3-(benzox- azol-2-yl)-2H-chromen-2-ones 17-21 (series B-I) and 3-(benzothiazol-2-yl)-2H-chromen-2-ones 22-28 (series B-II) were prepared as potential antitumor agents. The in vitro cytotoxic potency of the synthesized compounds was evaluated against five human cancer cell lines: DAN-G, A-427, LCLC-103H, RT-4 and SISO, and rela- tionships between structure and anticancer activity are discussed. Among the compounds tested, 3-(benzo[d] oxazol-2-yl)-N,N-diethyl-2-imino-2H-chromen-7-amine (6, series A-I) and 3-(benzo[d]thiazol-2-yl)-6-fluoro-2H- chromen-2-one (26, series B-II) exhibited the most potent cytotoxic activity with IC50 values ranging from <0.01 μM to 1.1 μM.